Jingfeng Pharmaceutical announced that the board of directors recently received a written resignation report from independent director Liu Ting. Due to personal reasons, he applied to resign as an independent director of the company, chairman of the board's remuneration and assessment committee, and a member of the nomination committee. After his resignation, he no longer held any position in the company. The original term of office ends on the date of the 8th board of directors. Since resignations will account for less than one-third of independent directors, their resignation application will take effect after the shareholders' meeting elects new independent directors, and they will still perform their duties during this period. As of the date of disclosure of the announcement, Liu Ting had no shares and had not fulfilled his promises. The board of directors will by-elect independent directors as soon as possible.

Jingfeng Pharmaceutical announced that the board of directors recently received a written resignation report from independent director Liu Ting. Due to personal reasons, he applied to resign as an independent director of the company, chairman of the board's remuneration and assessment committee, and a member of the nomination committee. After his resignation, he no longer held any position in the company. The original term of office ends on the date of the 8th board of directors. Since resignations will account for less than one-third of independent directors, their resignation application will take effect after the shareholders' meeting elects new independent directors, and they will still perform their duties during this period. As of the date of disclosure of the announcement, Liu Ting had no shares and had not fulfilled his promises. The board of directors will by-elect independent directors as soon as possible.